Welcome to Tech Beat, your daily look at what's moving in the world of technology.
Wired is out with its roundup of the best Android tablets heading into two thousand twenty six, and the field is genuinely competitive. OnePlus, Lenovo, and Google's Pixel are all making serious cases for your attention, whether you're looking for a couch companion or something that can actually replace a laptop. The trade-offs between price, performance, and software support are sharper than ever.
Shifting to crypto, Hyperliquid's HYPE token jumped double digits after ETF products tied to the platform pulled in twenty-five point five million dollars in new demand. What's notable here is that the buying pressure outpaced the token's own supply reduction mechanism, meaning the market moved faster than the protocol's built-in brakes. It's a reminder of how quickly institutional instruments can reshape a token's momentum.
And on the pharmaceutical front, a drug called retatrutide is drawing serious attention after trial results showed dramatic weight loss in participants. It's early stage, but the numbers are significant enough that researchers and investors alike are paying close attention. The obesity treatment space has already been transformed by GLP-one drugs, and this could represent the next chapter in that story.
That's what's worth watching today. Keep surfing. Tech Beat out.
